GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Debt-to-Revenue

Farmaceutica Remedia (BSE:RMAH) Debt-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Farmaceutica Remedia's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was lei0.9 Mil. Farmaceutica Remedia's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was lei1.2 Mil. Farmaceutica Remedia's annualized Revenue for the quarter that ended in Dec. 2023 was lei689.2 Mil. Farmaceutica Remedia's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.


Farmaceutica Remedia Debt-to-Revenue Historical Data

The historical data trend for Farmaceutica Remedia's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Debt-to-Revenue Chart

Farmaceutica Remedia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Farmaceutica Remedia Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Farmaceutica Remedia's Debt-to-Revenue

For the Medical Distribution subindustry, Farmaceutica Remedia's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Farmaceutica Remedia's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Farmaceutica Remedia's Debt-to-Revenue falls into.



Farmaceutica Remedia Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Farmaceutica Remedia's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.932 + 1.2) / 593.359
=0.00

Farmaceutica Remedia's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.932 + 1.2) / 689.164
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Farmaceutica Remedia Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines